We are live on ! Find out more
PC

PointState Capital Portfolio holdings

AUM $7.9B
1-Year Est. Return 42.31%
This Fund
S&P 500
This Quarter Est. Return
+9.27%
1 Year Est. Return
+42.31%
3 Year Est. Return
+142.91%
5 Year Est. Return
+261%
10 Year Est. Return
+1,945.58%
AUM
$5.06B
AUM Growth
-$266M
Cap. Flow
-$510M
Cap. Flow %
-10.09%
Top 10 Hldgs %
35.09%
Holding
173
New
46
Increased
33
Reduced
35
Closed
57

Top Buys

Rank Stock Value
1
INTU icon
Intuit
INTU
+$97.9M
2
WFC icon
Wells Fargo
WFC
+$95.3M
3
CSX icon
CSX Corp
CSX
+$81M
4
DVN icon
Devon Energy
DVN
+$70.7M
5
TMUS icon
T-Mobile US
TMUS
+$66.5M

Top Sells

Rank Stock Value
1
COF icon
Capital One
COF
+$191M
2
FISV
Fiserv Inc
FISV
+$156M
3
BABA icon
Alibaba
BABA
+$122M
4
MSFT icon
Microsoft
MSFT
+$114M
5
WDAY icon
Workday
WDAY
+$94.1M

Sector Composition

Rank Sector Weight
1 Technology 25.8%
2 Communication Services 11.16%
3 Healthcare 8.73%
4 Consumer Discretionary 5.33%
5 Financials 5.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COR icon
101
CALL
Cencora
COR
$62B
$4.43M 0.09%
+37,500
New +$4.06M
OSH
102
DELISTED
Oak Street Health, Inc.
OSH
$3.57M 0.07%
65,818
+21,818
+50% +$1.21M
ILMN icon
103
Illumina
ILMN
$29.5B
$3.46M 0.07%
+9,252
New +$3.77M
BNTX icon
104
BioNTech
BNTX
$23.5B
$3.02M 0.06%
27,700
+15,200
+122% +$1.61M
ELAN icon
105
CALL
Elanco Animal Health
ELAN
$13.2B
$2.94M 0.06%
+100,000
New +$3.08M
TDOC icon
106
Teladoc Health
TDOC
$1.66B
$2.73M 0.05%
15,000
-7,500
-33% -$1.74M
MRK icon
107
Merck
MRK
$322B
$2.7M 0.05%
36,680
-198,415
-84% -$14.6M
INNV icon
108
InnovAge Holding
INNV
$1.56B
$2.44M 0.05%
+94,500
New +$2.33M
DVA icon
109
DaVita
DVA
$15.5B
$2.42M 0.05%
22,500
-28,378
-56% -$3.15M
AVTR icon
110
CALL
Avantor
AVTR
$9.73B
$2.17M 0.04%
+75,000
New +$2.17M
ZBH icon
111
Zimmer Biomet
ZBH
$18.8B
$2.15M 0.04%
13,851
-12,002
-46% -$1.86M
PARA
112
DELISTED
Paramount Global Class B
PARA
$1.89M 0.04%
+42,000
New +$2.57M
LGF.A
113
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
$785K 0.02%
+52,500
New +$787K
NOVA
114
DELISTED
Sunnova Energy
NOVA
$302K 0.01%
+7,406
New +$329K
AGCB
115
DELISTED
Altimeter Growth Corp 2
AGCB
$282K 0.01%
+27,187
New +$325K
OTLKW
116
DELISTED
Outlook Therapeutics, Inc. Series A Warrant Expiring 02/18/2022
OTLKW
$101K ﹤0.01%
100,000
AER icon
117
AerCap
AER
$23.4B
-215,080
Closed -$9.8M
AFG icon
118
American Financial Group
AFG
$11.9B
-15,024
Closed -$1.32M
ALT icon
119
Altimmune
ALT
$568M
-50,000
Closed -$564K
AMD icon
120
Advanced Micro Devices
AMD
$700B
-328,589
Closed -$30.1M
APTV icon
121
Aptiv
APTV
$12.3B
-6,347
Closed -$827K
BABA icon
122
CALL
Alibaba
BABA
$276B
-400,000
Closed -$93.1M
BABA icon
123
Alibaba
BABA
$276B
-524,644
Closed -$122M
BIIB icon
124
CALL
Biogen
BIIB
$30.9B
-38,500
Closed -$9.43M
BKNG icon
125
Booking.com
BKNG
$156B
-227,725
Closed -$20.3M

Similar funds

PointState Capital's Q1 2021 Portfolio in Review

As of Q1 2021, PointState Capital held 173 positions worth $5.06B, down 5% from $5.32B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

PointState Capital withdrew a net $510M in Q1 2021, closing 57 positions and reducing 35 holdings. Its most notable exit was Alibaba, an estimated $122M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 33% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, PointState Capital opened a new position in CSX Corp worth $85.3M.

  • PointState Capital's largest Q1 2021 buy was CSX Corp: 2,655,054 shares worth $85.3M.
  • PointState Capital added most to Intuit in Q1 2021, an estimated $97.9M increase.
  • PointState Capital's biggest Q1 2021 reduction was Capital One, cutting an estimated $191M.
  • PointState Capital fully exited Alibaba in Q1 2021, selling an estimated $122M.
  • PointState Capital's ten largest holdings make up 35% of its $5.06B portfolio in Q1 2021.
  • PointState Capital opened 46 new positions and closed 57 in Q1 2021.
  • PointState Capital's portfolio value fell 5% quarter-over-quarter to $5.06B.

Based on PointState Capital's 13F filing for Q1 2021, filed 14 May 2021.